Literature DB >> 33981139

Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review.

Martina Votto1,2, Maria De Filippo1,2, Amelia Licari1,2, Alessia Marseglia2, Mara De Amici3, Gian Luigi Marseglia1,2.   

Abstract

Severe uncontrolled asthma is a complex and heterogeneous disease. A multidisciplinary assessment is required to correctly identify and manage children and adolescents with severe asthma because they may require strict monitoring and additional treatment with advanced targeted therapies. Recent research efforts have focused on identifying epidemiologic, clinical, and molecular mechanisms that underlie severe asthma, leading to the recognition of different phenotypes and endotypes and identifying biomarkers able to predict the response to biologic therapies. Additional progress has occurred by introducing biological therapies that have revolutionized the care of chronic allergic diseases in the adult and pediatric population. In this review, we briefly summarized the current literature on biological therapies to treat severe asthma in children and adolescents.
© 2021 Votto et al.

Entities:  

Keywords:  adolescents; biological therapy; children; endotype; phenotype; severe asthma

Year:  2021        PMID: 33981139      PMCID: PMC8107006          DOI: 10.2147/BTT.S252574

Source DB:  PubMed          Journal:  Biologics        ISSN: 1177-5475


  4 in total

Review 1.  Severe Pediatric Asthma Therapy: Mepolizumab.

Authors:  Nicola Ullmann; Francesca Peri; Olivia Florio; Federica Porcaro; Elisa Profeti; Alessandro Onofri; Renato Cutrera
Journal:  Front Pediatr       Date:  2022-07-01       Impact factor: 3.569

2.  New opportunities with biologic treatments in pediatric allergic and respiratory diseases.

Authors:  Laura Tenero; Giorgio Piacentini
Journal:  Pediatr Allergy Immunol       Date:  2022-01       Impact factor: 5.464

3.  Rapid response to dupilumab treatment in children with moderate-to-severe atopic dermatitis: A case series.

Authors:  Martina Votto; Francesco Delle Cave; Maria De Filippo; Alessia Marseglia; Gian Luigi Marseglia; Valeria Brazzelli; Amelia Licari
Journal:  Pediatr Allergy Immunol       Date:  2022-01       Impact factor: 5.464

Review 4.  Non-invasive biomarkers of eosinophilic esophagitis.

Authors:  Martina Votto; Maria De Filippo; Riccardo Castagnoli; Francesco Delle Cave; Francesca Giffoni; Viola Santi; Marta Vergani; Carlo Caffarelli; Mara De Amici; Gian Luigi Marseglia; Amelia Licari
Journal:  Acta Biomed       Date:  2021-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.